Bayer to test antibiotic on TB

Oct. 19, 2005 at 3:06 AM

NEW YORK, Oct. 19 (UPI) -- The German pharmaceutical company Bayer HealthCare plans tests to determine if its newest antibiotic is effective against tuberculosis.

The New York Times said that no new drugs against tuberculosis have been registered in 40 years. Most drug companies do not test patented pharmaceuticals against diseases associated with poverty.

Bayer said that if moxifloxacin shortens TB treatment it will provide millions of doses for poor countries.

The trials are being funded by the Bill and Melinda Gates Foundation and by the Centers for Disease Control and Prevention, the new European and Developing Countries Clinical Trials Partnership and the Food and Drug Administration.

Related UPI Stories
Latest Headlines
Trending Stories
Ted Cruz campaign pulls ad featuring softcore porn actress
Report: Clinton Foundation subpoenaed by State Dept. watchdog over charity projects
Ruby Rose, Gigi Hadid react to Kanye West's lyric about Taylor Swift
Kristen Wiig impersonates Peyton Manning on 'The Tonight Show'
NYC police officer found guilty of manslaughter in Brooklyn stairway shooting